133 related articles for article (PubMed ID: 1719731)
21. [Isovolemic hemodilution in stage-IIb peripheral arterial occlusive diseases. Prospective randomized double-blind comparison of middle-molecule hydroxyethyl starch and electrolyte solution].
Kiesewetter H; Jung F; Blume J; Gerhards M
Dtsch Med Wochenschr; 1986 Aug; 111(35):1307-12. PubMed ID: 2427301
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of 2 6% middle-molecular hydroxyethyl starch solutions on elimination kinetics and flow characteristics of blood in volunteers].
Koscielny J; Jung F; Mrowietz C; Pindur G; Förster H; Schimetta W; Kiesewetter H; Wenzel E
Infusionsther Transfusionsmed; 1994 Aug; 21(4):251-9. PubMed ID: 7524833
[TBL] [Abstract][Full Text] [Related]
23. [Hemodilution therapy of arterial occlusive diseases using hydroxyethyl starch 200/0,5].
Müller-Bühl U; Comberg HU; Diehm C; Allenberg J; Mörl H
MMW Munch Med Wochenschr; 1982 Mar; 124(10):241-3. PubMed ID: 6178019
[No Abstract] [Full Text] [Related]
24. [Effect of stepwise hypervolemic versus isovolemic hemodilution in patients with intermittent claudication on muscle oxygen pressure during exercise].
Höffkes HG; Saeger-Lorenz K; Ehrly AM
Vasa; 1991; 20(2):109-18. PubMed ID: 1877329
[TBL] [Abstract][Full Text] [Related]
25. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic infusions of middle molecular weight hydroxyethyl starch (10%, 200,000/0.62) in healthy probands].
Scheffler P; Jung F; Mrowietz C; Waldhausen P; Leipnitz G; Häuser B
Infusionsther Klin Ernahr; 1987 Oct; 14(5):233-8. PubMed ID: 2445681
[TBL] [Abstract][Full Text] [Related]
26. [Effect of hemodilution with plasma protein solution and hydroxyethyl starch on plasma fibronectin].
Khosropour R; Graninger W; Lackner F
Anasth Intensivther Notfallmed; 1984 Aug; 19(4):175-8. PubMed ID: 6208807
[TBL] [Abstract][Full Text] [Related]
27. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
Winter V; Gille J; Richter A; Sablotzki A; Wiedemann B
Anesteziol Reanimatol; 2006; (2):43-7. PubMed ID: 16758944
[TBL] [Abstract][Full Text] [Related]
28. [Effect of a 10% and 6% hydroxyethyl starch solution (molecular weight 200,000/0.62) in comparison with a 10% dextran solution (molecular weight 40,000) on flow properties of blood and tissue oxygen pressure in patients with intermittent claudication].
Ehrly AM; Seebens H; Saeger-Lorenz K
Infusionstherapie; 1988 Oct; 15(5):181-7. PubMed ID: 2461906
[TBL] [Abstract][Full Text] [Related]
29. [Hypervolemic hemodilution with bloodletting in patients with peripheral arterial occlusive disease].
Kiesewetter H; Blume HJ; Jung F; Bach R; Spitzer S; Leipnitz G; Schieffer H; Bette L; Wenzel E
Vasa Suppl; 1988; 26():107-12. PubMed ID: 2462283
[No Abstract] [Full Text] [Related]
30. [Hypertonic-hyperoncotic volume replacement (7.5% NaCl/10% hydroxyethyl starch 200.000/0.5) in patients with coronary artery stenoses].
Prien T; Thülig B; Wüsten R; Schoofs J; Weyand M; Lawin P
Zentralbl Chir; 1993; 118(5):257-63; discussion 264-6. PubMed ID: 7686707
[TBL] [Abstract][Full Text] [Related]
31. The influence of I.V. application of pentoxifylline on the viscoelasticity of blood in patients with peripheral vascular disorders.
Chmiel H; Anadere I; Heimburg P
Ric Clin Lab; 1981; 11 Suppl 1():189-96. PubMed ID: 7188108
[TBL] [Abstract][Full Text] [Related]
32. [Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran].
Ernst E; Kollar L; Matrai A
Acta Med Austriaca; 1991; 18 Suppl 1():27-9. PubMed ID: 1719730
[TBL] [Abstract][Full Text] [Related]
33. [Non-arteritic anterior ischemic optic neuropathy: long-term results after hemodilution therapy].
Haas A; Uyguner I; Sochor GE; Schmut O; Vidic B; Faulborn J
Klin Monbl Augenheilkd; 1994 Sep; 205(3):143-6. PubMed ID: 7527879
[TBL] [Abstract][Full Text] [Related]
34. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
Treib J; Haass A; Pindur G; Grauer MT; Jung F; Wenzel E; Schimrigk K
Arzneimittelforschung; 1997 Jan; 47(1):18-22. PubMed ID: 9037438
[TBL] [Abstract][Full Text] [Related]
35. [Hemodilution, hemorheology and oxygen supply].
Ehrly AM
Acta Med Austriaca; 1991; 18 Suppl 1():3-8. PubMed ID: 1950386
[TBL] [Abstract][Full Text] [Related]
36. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
Pöhlmann G; Braumann A; Grohmann G
Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
[No Abstract] [Full Text] [Related]
37. [Treadmill ergometer multistage test: a new alternative in diagnosis and therapeutic control of peripheral arterial occlusive disease].
Weidinger P; Bachl N; Liebenberger S
Vasa Suppl; 1988; 26():48-50. PubMed ID: 2462285
[No Abstract] [Full Text] [Related]
38. [Hypervolemic hemodilution as a means of preventing homologous blood transfusion. A simple alternative to acute normovolemic hemodilution].
Entholzner E; Mielke L; Plötz W; Malek A; Kling M; Burgkart R; Hargasser S; Hipp R
Fortschr Med; 1994 Oct; 112(29):410-4. PubMed ID: 7528160
[TBL] [Abstract][Full Text] [Related]
39. [Hemodilution in acute arterial circulatory disorders of the retina].
Arend O; Hoberg A; Bertram B; Reim M; Wolf S
Acta Med Austriaca; 1991; 18 Suppl 1():66-8. PubMed ID: 1719735
[TBL] [Abstract][Full Text] [Related]
40. [Conjunctival oxygen partial pressure, hemorheology and circulatory parameters in acute cerebral infarct before and following infusion of 6 percent low molecular hydroxyethyl starch].
Kortsik CS; Staedt U; Stein T; Geiger G; Buss J
Infusionstherapie; 1990 Apr; 17(2):79-82. PubMed ID: 1693909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
